Medicare’s Aducanumab Decision Highlights Needed Reforms To FDA And CMS Regulatory Pathways Health Affairs, 25 Jan 2022 Much ink has already been spilled to parse the Centers for Medicare and Medicaid Services’ (CMS’s) January 11 draft national…